A carregar...
Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
AIM: Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of this meta‐analysis and systematic review was to quantify the effect of doxorubicin on skeletal muscle and report on the proposed molecular pathways possibly leading to doxorubicin‐induced muscle atrophy...
Na minha lista:
| Publicado no: | Acta Physiol (Oxf) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317437/ https://ncbi.nlm.nih.gov/pubmed/31600860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apha.13400 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|